Additive manufacturing leveraged microfluidic setup for sample to answer colorimetric detection of pathogens
Sripadh Guptha Yedire1, Imman Isaac Hosseini1, Hamed Shieh1
1Department of Bioengineering, McGill University, Montréal, QC, H3A 0C3, Canada. sara.mahshid@mcgill.ca.
Lab on a Chip
|September 1, 2023
Summary
This study introduces a novel, automated smartphone-operated device for rapid infectious disease detection using colorimetric loop-mediated isothermal amplification (LAMP). The system enables quick, reliable results at the point of care, overcoming previous limitations.
Area of Science:
- Biomedical Engineering
- Point-of-Care Diagnostics
- Molecular Assays
Background:
- Colorimetric detection integrated with loop-mediated isothermal amplification (LAMP) offers potential for point-of-care infectious disease diagnostics.
- Current methods face challenges in rapidity, user variability, signal quantification, and complex manual steps, limiting clinical application.
Purpose of the Study:
- To develop and validate a novel, automated, smartphone-operated system for rapid, colorimetric detection of infectious diseases.
- To address limitations of existing LAMP-based colorimetric assays, including speed, reproducibility, and ease of use.
Main Methods:
- An integrated system comprising an additively manufactured microfluidic cartridge, a portable reflected-light imaging setup with controlled epi-illumination (PRICE) module, and a control/data analysis module was designed.
- The microfluidic cartridge automates sample preparation, reagent mixing, and isothermal amplification using tunable elastomeric chambers and actuators.
- The PRICE module captures colorimetric changes on a plasmonic nanostructured substrate for quantitative analysis.
Main Results:
- The automated system successfully detected SARS-CoV-2 wild-type RNA.
- A rapid turnaround time of 13 minutes was achieved for nucleic acid detection.
- Individual components were characterized, demonstrating the feasibility of the integrated device.
Conclusions:
- The developed smartphone-operated automated setup offers a robust solution for rapid, point-of-care molecular diagnostics.
- This technology has the potential to be adapted for various molecular assays requiring sequential fluid handling.
- The system addresses key challenges, paving the way for improved infectious disease detection in resource-limited settings.


